General Information of Drug (ID: DMOY627)

Drug Name
P(1)-(6-Hydroxymethylpterin)-P(4)-(5'-adenosyl)tetraphosphate Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
56603783
TTD Drug ID
DMOY627

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Preclinical Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PD-157695 DMDSR1X Schizophrenia 6A20 Preclinical [1]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [2]
[3H]alphabeta-meATP DMWV5C3 Discovery agent N.A. Investigative [2]
[Pterin-6-Yl Methanyl]-Phosphonophosphate DM4ZY79 Discovery agent N.A. Investigative [2]
6-Hydroxymethyl-7,8-Dihydropterin DMYF60K Discovery agent N.A. Investigative [2]
6-Hydroxymethylpterin DM7EWDN Discovery agent N.A. Investigative [3]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Hydroxymethyl-dihydropterin pyrophosphokinase (Bact folK) TT38ECI HPPK_ECOLI Inhibitor [1]

References

1 Bisubstrate analogue inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase: synthesis and biochemical and crystallographic studies. J Med Chem. 2001 Apr 26;44(9):1364-71.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.